Using Vitamin B12 and Dextrose to Treat Carpal Tunnel Syndrome
The Effects of Vitamin B12 and Dextrose on the Ultrasound-guided Median Nerve Hydrodissection
NA · National Cheng-Kung University Hospital · NCT05423028
This study is testing if injections of vitamin B12 and dextrose can help relieve symptoms and improve function for people with carpal tunnel syndrome.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | All |
| Sponsor | National Cheng-Kung University Hospital (other) |
| Locations | 1 site (Tainan) |
| Trial ID | NCT05423028 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of ultrasound-guided median nerve hydrodissection using 5% dextrose and vitamin B12 for treating carpal tunnel syndrome. It is a prospective, double-blind randomized control trial designed to compare the outcomes of different injection agents on patients diagnosed with this condition. The study aims to provide evidence on whether these treatments can alleviate symptoms and improve function in affected individuals.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 20-80 who have been diagnosed with carpal tunnel syndrome confirmed by an electrophysiological study.
Not a fit: Patients who have previously undergone wrist surgery or steroid injections for carpal tunnel syndrome, or those with certain medical conditions such as thrombocytopenia or autoimmune diseases, may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could offer a non-surgical option for patients suffering from carpal tunnel syndrome, potentially reducing pain and improving hand function.
How similar studies have performed: Previous studies have shown promising results with ultrasound-guided hydrodissection for carpal tunnel syndrome, but the combination of vitamin B12 with this approach is less established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 20-80 year-old. * Diagnosis (carpal tunnel syndrome) was confirmed using an electrophysiological study. Exclusion Criteria: * Previously undergone wrist surgery or steroid injection for CTS * Thrombocytopenia * Coagulopathy * Inflammation status * Polyneuropathy * Brachial plexopathy * Cervical radiculopathy * Autoimmune disease * Malignancy * Pregnancy Thoracic outlet syndrome
Where this trial is running
Tainan
- Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University — Tainan, Taiwan (RECRUITING)
Study contacts
- Study coordinator: Yao-Hong Guo, MD, MSc
- Email: drprps@gmail.com
- Phone: 886-6-2353535
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Carpal Tunnel Syndrome